ARROWHEAD PHARMACEUTICALS, INC. Common Stock, Capital Shares Reserved for Future Issuance
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Common Stock, Capital Shares Reserved for Future Issuance of 467.32 thousand shares as of 2014-09-30, per its 10-K filed 2014-11-25.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2014-11-25
- 2014-09-30: Common Stock, Capital Shares Reserved for Future Issuance 467.32K shares.
- 2014-06-30: Common Stock, Capital Shares Reserved for Future Issuance 410.08K shares.
- 2014-03-31: Common Stock, Capital Shares Reserved for Future Issuance 417.41K shares.
- 2013-12-31: Common Stock, Capital Shares Reserved for Future Issuance 395.95K shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2014-09-30 | 467.32K shares 10-K · filed 2014-11-25 |
| 2014-06-30 | 410.08K shares 10-Q · filed 2014-08-12 |
| 2014-03-31 | 417.41K shares 10-Q · filed 2014-05-06 |
| 2013-12-31 | 395.95K shares 10-Q · filed 2014-02-04 |
| 2013-06-30 | 6.06M shares 10-Q · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |